1 Short Bowel Syndrome Drugs Market Overview 1.1 Product Overview and Scope of Short Bowel Syndrome Drugs 1.2 Short Bowel Syndrome Drugs Segment by Type 1.2.1 Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Oral Short Bowel Syndrome Drugs 1.2.3 Tablet Short Bowel Syndrome Drugs 1.3 Short Bowel Syndrome Drugs Segment by Sale Channel 1.3.1 Global Short Bowel Syndrome Drugs Sales Comparison by Sale Channel: (2022-2028) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Short Bowel Syndrome Drugs Market Size Estimates and Forecasts 1.4.1 Global Short Bowel Syndrome Drugs Revenue 2017-2028 1.4.2 Global Short Bowel Syndrome Drugs Sales 2017-2028 1.4.3 Short Bowel Syndrome Drugs Market Size by Region: 2017 Versus 2021 Versus 2028 2 Short Bowel Syndrome Drugs Market Competition by Manufacturers 2.1 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022) 2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Short Bowel Syndrome Drugs Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Short Bowel Syndrome Drugs Manufacturing Sites, Area Served, Product Type 2.5 Short Bowel Syndrome Drugs Market Competitive Situation and Trends 2.5.1 Short Bowel Syndrome Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Short Bowel Syndrome Drugs Players Market Share by Revenue 2.5.3 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Short Bowel Syndrome Drugs Retrospective Market Scenario by Region 3.1 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Short Bowel Syndrome Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Short Bowel Syndrome Drugs Market Facts & Figures by Country 3.3.1 North America Short Bowel Syndrome Drugs Sales by Country 3.3.2 North America Short Bowel Syndrome Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Short Bowel Syndrome Drugs Market Facts & Figures by Country 3.4.1 Europe Short Bowel Syndrome Drugs Sales by Country 3.4.2 Europe Short Bowel Syndrome Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Short Bowel Syndrome Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region 3.5.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Short Bowel Syndrome Drugs Market Facts & Figures by Country 3.6.1 Latin America Short Bowel Syndrome Drugs Sales by Country 3.6.2 Latin America Short Bowel Syndrome Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Short Bowel Syndrome Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country 3.7.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Short Bowel Syndrome Drugs Historic Market Analysis by Type 4.1 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022) 4.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2022) 4.3 Global Short Bowel Syndrome Drugs Price by Type (2017-2022) 5 Global Short Bowel Syndrome Drugs Historic Market Analysis by Sale Channel 5.1 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022) 5.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2022) 5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022) 6 Key Companies Profiled 6.1 Emmaus Medical 6.1.1 Emmaus Medical Corporation Information 6.1.2 Emmaus Medical Description and Business Overview 6.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Emmaus Medical Short Bowel Syndrome Drugs Product Portfolio 6.1.5 Emmaus Medical Recent Developments/Updates 6.2 Merck 6.2.1 Merck Corporation Information 6.2.2 Merck Description and Business Overview 6.2.3 Merck Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Merck Short Bowel Syndrome Drugs Product Portfolio 6.2.5 Merck Recent Developments/Updates 6.3 Takeda 6.3.1 Takeda Corporation Information 6.3.2 Takeda Description and Business Overview 6.3.3 Takeda Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Takeda Short Bowel Syndrome Drugs Product Portfolio 6.3.5 Takeda Recent Developments/Updates 6.4 Ardelyx 6.4.1 Ardelyx Corporation Information 6.4.2 Ardelyx Description and Business Overview 6.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Ardelyx Short Bowel Syndrome Drugs Product Portfolio 6.4.5 Ardelyx Recent Developments/Updates 6.5 Naia Pharmaceuticals 6.5.1 Naia Pharmaceuticals Corporation Information 6.5.2 Naia Pharmaceuticals Description and Business Overview 6.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio 6.5.5 Naia Pharmaceuticals Recent Developments/Updates 6.6 Nutrinia 6.6.1 Nutrinia Corporation Information 6.6.2 Nutrinia Description and Business Overview 6.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Nutrinia Short Bowel Syndrome Drugs Product Portfolio 6.6.5 Nutrinia Recent Developments/Updates 6.7 OxThera 6.6.1 OxThera Corporation Information 6.6.2 OxThera Description and Business Overview 6.6.3 OxThera Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.4.4 OxThera Short Bowel Syndrome Drugs Product Portfolio 6.7.5 OxThera Recent Developments/Updates 6.8 GLyPharma Therapeutic 6.8.1 GLyPharma Therapeutic Corporation Information 6.8.2 GLyPharma Therapeutic Description and Business Overview 6.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Portfolio 6.8.5 GLyPharma Therapeutic Recent Developments/Updates 6.9 Sancilio Pharmaceuticals 6.9.1 Sancilio Pharmaceuticals Corporation Information 6.9.2 Sancilio Pharmaceuticals Description and Business Overview 6.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio 6.9.5 Sancilio Pharmaceuticals Recent Developments/Updates 6.10 Zealand Pharma 6.10.1 Zealand Pharma Corporation Information 6.10.2 Zealand Pharma Description and Business Overview 6.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Zealand Pharma Short Bowel Syndrome Drugs Product Portfolio 6.10.5 Zealand Pharma Recent Developments/Updates 7 Short Bowel Syndrome Drugs Manufacturing Cost Analysis 7.1 Short Bowel Syndrome Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Short Bowel Syndrome Drugs 7.4 Short Bowel Syndrome Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Short Bowel Syndrome Drugs Distributors List 8.3 Short Bowel Syndrome Drugs Customers 9 Short Bowel Syndrome Drugs Market Dynamics 9.1 Short Bowel Syndrome Drugs Industry Trends 9.2 Short Bowel Syndrome Drugs Market Drivers 9.3 Short Bowel Syndrome Drugs Market Challenges 9.4 Short Bowel Syndrome Drugs Market Restraints 10 Global Market Forecast 10.1 Short Bowel Syndrome Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Type (2023-2028) 10.2 Short Bowel Syndrome Drugs Market Estimates and Projections by Sale Channel 10.2.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Sale Channel (2023-2028) 10.2.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Sale Channel (2023-2028) 10.3 Short Bowel Syndrome Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Short Bowel Syndrome Drugs by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Short Bowel Syndrome Drugs by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million) Table 2. Global Short Bowel Syndrome Drugs Sales Growth Rate Comparison by Sale Channel (2022-2028) & (K Pcs) & (US$ Million) Table 3. Global Short Bowel Syndrome Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Short Bowel Syndrome Drugs Market Competitive Situation by Manufacturers in 2021 Table 5. Global Short Bowel Syndrome Drugs Sales (K Pcs) of Key Manufacturers (2017-2022) Table 6. Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022) Table 7. Global Short Bowel Syndrome Drugs Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Short Bowel Syndrome Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022) Table 10. Manufacturers Short Bowel Syndrome Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Short Bowel Syndrome Drugs Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Short Bowel Syndrome Drugs as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs) Table 16. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022) Table 17. Global Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022) Table 19. North America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs) Table 20. North America Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022) Table 21. North America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022) Table 23. Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs) Table 24. Europe Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022) Table 25. Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs) Table 28. Asia Pacific Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022) Table 31. Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs) Table 32. Latin America Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022) Table 33. Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs) Table 36. Middle East and Africa Short Bowel Syndrome Drugs Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Short Bowel Syndrome Drugs Revenue Market Share by Country (2017-2022) Table 39. Global Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs) Table 40. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2022) Table 41. Global Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Short Bowel Syndrome Drugs Revenue Share by Type (2017-2022) Table 43. Global Short Bowel Syndrome Drugs Price by Type (2017-2022) & (USD/Pcs) Table 44. Global Short Bowel Syndrome Drugs Sales (K Pcs) by Sale Channel (2017-2022) Table 45. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2022) Table 46. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million) Table 47. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2017-2022) Table 48. Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022) & (USD/Pcs) Table 49. Emmaus Medical Corporation Information Table 50. Emmaus Medical Description and Business Overview Table 51. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 52. Emmaus Medical Short Bowel Syndrome Drugs Product Table 53. Emmaus Medical Recent Developments/Updates Table 54. Merck Corporation Information Table 55. Merck Description and Business Overview Table 56. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 57. Merck Short Bowel Syndrome Drugs Product Table 58. Merck Recent Developments/Updates Table 59. Takeda Corporation Information Table 60. Takeda Description and Business Overview Table 61. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 62. Takeda Short Bowel Syndrome Drugs Product Table 63. Takeda Recent Developments/Updates Table 64. Ardelyx Corporation Information Table 65. Ardelyx Description and Business Overview Table 66. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 67. Ardelyx Short Bowel Syndrome Drugs Product Table 68. Ardelyx Recent Developments/Updates Table 69. Naia Pharmaceuticals Corporation Information Table 70. Naia Pharmaceuticals Description and Business Overview Table 71. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 72. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Table 73. Naia Pharmaceuticals Recent Developments/Updates Table 74. Nutrinia Corporation Information Table 75. Nutrinia Description and Business Overview Table 76. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 77. Nutrinia Short Bowel Syndrome Drugs Product Table 78. Nutrinia Recent Developments/Updates Table 79. OxThera Corporation Information Table 80. OxThera Description and Business Overview Table 81. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 82. OxThera Short Bowel Syndrome Drugs Product Table 83. OxThera Recent Developments/Updates Table 84. GLyPharma Therapeutic Corporation Information Table 85. GLyPharma Therapeutic Description and Business Overview Table 86. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 87. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Table 88. GLyPharma Therapeutic Recent Developments/Updates Table 89. Sancilio Pharmaceuticals Corporation Information Table 90. Sancilio Pharmaceuticals Description and Business Overview Table 91. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 92. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Table 93. Sancilio Pharmaceuticals Recent Developments/Updates Table 94. Zealand Pharma Corporation Information Table 95. Zealand Pharma Description and Business Overview Table 96. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 97. Zealand Pharma Short Bowel Syndrome Drugs Product Table 98. Zealand Pharma Recent Developments/Updates Table 99. Production Base and Market Concentration Rate of Raw Material Table 100. Key Suppliers of Raw Materials Table 101. Short Bowel Syndrome Drugs Distributors List Table 102. Short Bowel Syndrome Drugs Customers List Table 103. Short Bowel Syndrome Drugs Market Trends Table 104. Short Bowel Syndrome Drugs Market Drivers Table 105. Short Bowel Syndrome Drugs Market Challenges Table 106. Short Bowel Syndrome Drugs Market Restraints Table 107. Global Short Bowel Syndrome Drugs Sales Forecast by Type (2023-2028) & (K Pcs) Table 108. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Type (2023-2028) Table 109. Global Short Bowel Syndrome Drugs Revenue Forecast by Type (2023-2028) & (US$ Million) Table 110. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Type (2023-2028) Table 111. Global Short Bowel Syndrome Drugs Sales Forecast by Sale Channel (2023-2028) & (K Pcs) Table 112. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Sale Channel (2023-2028) Table 113. Global Short Bowel Syndrome Drugs Revenue Forecast by Sale Channel (2023-2028) & (US$ Million) Table 114. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Sale Channel (2023-2028) Table 115. Global Short Bowel Syndrome Drugs Sales Forecast by Region (2023-2028) & (K Pcs) Table 116. Global Short Bowel Syndrome Drugs Sales Market Share Forecast by Region (2023-2028) Table 117. Global Short Bowel Syndrome Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 118. Global Short Bowel Syndrome Drugs Revenue Market Share Forecast by Region (2023-2028) Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Short Bowel Syndrome Drugs Figure 2. Global Short Bowel Syndrome Drugs Market Share by Type in 2021 & 2028 Figure 3. Oral Short Bowel Syndrome Drugs Product Picture Figure 4. Tablet Short Bowel Syndrome Drugs Product Picture Figure 5. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2021 & 2028 Figure 6. Hospital Pharmacies Figure 7. Retail Pharmacies Figure 8. Online Pharmacies Figure 9. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Short Bowel Syndrome Drugs Market Size (2017-2028) & (US$ Million) Figure 11. Global Short Bowel Syndrome Drugs Sales (2017-2028) & (K Pcs) Figure 12. Short Bowel Syndrome Drugs Sales Share by Manufacturers in 2021 Figure 13. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Short Bowel Syndrome Drugs Players: Market Share by Revenue in 2021 Figure 15. Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022) Figure 17. Global Short Bowel Syndrome Drugs Sales Market Share by Region in 2021 Figure 18. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022) Figure 19. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in 2021 Figure 20. U.S. Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Turkey Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Saudi Arabia Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. UAE Short Bowel Syndrome Drugs Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Sales Market Share of Short Bowel Syndrome Drugs by Type (2017-2022) Figure 43. Manufacturing Cost Structure of Short Bowel Syndrome Drugs Figure 44. Manufacturing Process Analysis of Short Bowel Syndrome Drugs Figure 45. Short Bowel Syndrome Drugs Industrial Chain Analysis Figure 46. Channels of Distribution Figure 47. Distributors Profiles Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Emmaus Medical Merck Takeda Ardelyx Naia Pharmaceuticals Nutrinia OxThera GLyPharma Therapeutic Sancilio Pharmaceuticals Zealand Pharma